STAA
STAAR Surgical Company
NASDAQ: STAA · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$26.69
-2.16% today
Updated 2026-05-08
Market cap
$1.36B
P/E ratio
—
P/S ratio
5.67x
EPS (TTM)
$-1.62
Dividend yield
—
52W range
$16 – $31
Volume
1.2M
WallStSmart proprietary scores
37
out of 100
Grade: D
Sell
Investment rating
4.0
Growth
C8.0
Quality
A2.0
Profitability
F7.7
Valuation
B+2/9
Piotroski F-Score
Weak
2.8
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →195 stocks currently score above 75
Price targets
Analyst target
$21.11
-20.91%
12-Month target
—
—
Intrinsic (DCF)
$29.00
Margin of safety
+40.52%
0 Strong Buy1 Buy10 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Revenue growth 18.10% QoQ
+ 40.52% below intrinsic value
+ Debt/equity 0.11x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Thin margins at -33.60%
- Negative free cash flow $-1.68M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $284.39M | $322.42M | $313.90M | $239.44M | $239.44M |
| Net income | $39.66M | $21.35M | $-20.21M | $-80.45M | $-18.31M |
| EPS | — | — | — | — | $-1.62 |
| Free cash flow | $17.61M | $-3.59M | $-7.67M | $-40.05M | $-1.68M |
| Profit margin | 13.95% | 6.62% | -6.44% | -33.60% | -33.60% |
Peer comparison
Smart narrative
STAAR Surgical Company trades at $26.69. Our Smart Value Score of 37/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 2.81, it sits in the grey zone. TTM revenue stands at $239.44M. with profit margins at -33.60%. Our DCF model estimates intrinsic value at $29.00.
Frequently asked questions
What is STAAR Surgical Company's stock price?
STAAR Surgical Company (STAA) trades at $26.69.
Is STAAR Surgical Company overvalued?
Smart Value Score 37/100 (Grade D, Sell). DCF value $29.00.
What is the price target of STAAR Surgical Company (STAA)?
The analyst target price is $21.11, representing -20.9% downside from the current price of $26.69.
What is the intrinsic value of STAAR Surgical Company (STAA)?
Based on our DCF model, intrinsic value is $29.00, a +40.5% margin of safety versus $26.69.
What is STAAR Surgical Company's revenue?
TTM revenue is $239.44M.
Piotroski F-Score?
2/9 — weak financial health.
Altman Z-Score?
2.81 — grey zone.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio5.67x
ROE-21.70%
Beta1.20
50D MA$21.85
200D MA$23.64
Shares out0.05B
Float0.03B
Short ratio—
Avg volume1.2M
Performance
1 week+12.97%
1 month+9.48%
3 months-14.36%
YTD-12.47%
1 year—
3 years—
5 years—